Samsung Electronics Becomes Largest Shareholder in U.S. Genomics Firm, Expanding Beyond Semiconductors into Precision Medicine

Samsung Electronics has taken a major stake in Element Biosciences, a U.S.-based genetic analysis equipment company, becoming its largest shareholder as part of a strategic push into the precision medicine market.